Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/29/2025

Treatment Options for Nocturnal Enuresis (Bedwetting)

Initial Assessment and Education

  • The American Academy of Pediatrics recommends educating families that bedwetting is common (15-20% of 5-year-olds) with a spontaneous remission rate of approximately 14% per year to reduce parental guilt and avoid punitive responses 1
  • Completing a frequency-volume chart or bladder diary for at least 1 week is recommended to establish baseline patterns and detect underlying issues 2
  • Urinalysis is recommended to rule out conditions like diabetes mellitus, urinary tract infection, or kidney disease 1
  • Assessing for constipation is recommended, as treating it can lead to resolution of urinary symptoms in up to 63% of cases with nocturnal enuresis 2

Behavioral Interventions

  • Implementing a reward system (sticker chart) for dry nights is recommended to increase motivation and awareness 1
  • Establishing regular daytime voiding schedules (morning, at least twice during school, after school, dinner time, and bedtime) is recommended 1
  • Minimizing evening fluid intake, particularly caffeinated beverages, while ensuring adequate hydration earlier in the day is recommended 2
  • Addressing constipation aggressively with polyethylene glycol if needed is recommended 2
  • Involving the child in changing wet bedding is recommended to raise awareness (not as punishment) 1
  • Encouraging physical activity during the day is recommended 1

Alarm Therapy

  • Providing written instructions, establishing a contract, and scheduling frequent monitoring appointments are recommended to enhance success with enuresis alarms 2
  • Expecting treatment to continue for at least 2-3 months before attempting to wean is recommended 2

Pharmacological Options

  • Considering desmopressin for children with nocturnal polyuria when alarm therapy has failed or is unlikely to be successful is recommended 3
  • The typical oral dose of desmopressin is 0.2 to 0.4 mg tablets or 120 to 240 mg melt formulation, taken 1 hour before bedtime 3
  • Limiting fluid intake to 200 ml (6 ounces) or less in the evening and no drinking until morning is recommended to prevent hyponatremia 3
  • Expecting an immediate anti-enuretic effect with approximately 30% full response and 40% partial response rates is recommended 1, 2
  • Considering anticholinergics as second-line therapy for children with suspected detrusor overactivity when standard treatments have failed is recommended 3
  • Options for anticholinergics include oxybutynin, tolterodine, and propiverine 3
  • Typical dosing is 2 mg tolterodine, 5 mg oxybutynin, or 0.4 mg/kg propiverine at bedtime 3
  • Monitoring for constipation and post-void residual urine that may cause UTIs is recommended 3
  • Considering imipramine only as third-line therapy at tertiary care facilities due to safety concerns is recommended 3
  • Approximately 50% of children with therapy-resistant enuresis respond to imipramine 3

Combination Approaches for Resistant Cases

  • Combining alarm therapy with desmopressin is recommended for children not responding to single modalities 2
  • Combining behavioral therapy and medication may be necessary in cases with mixed disorders 2
  • Prioritizing treating constipation first before escalating urinary treatments is recommended if constipation and urinary symptoms coexist 2

Important Considerations and Pitfalls

  • Avoiding punishing, shaming, or creating control struggles around bedwetting is recommended as it can worsen the situation and create psychological distress 1
  • Scheduling monthly follow-up appointments is recommended to sustain motivation and assess treatment response 2
  • Reassessing the diagnosis and considering referral to a specialist is recommended if no improvement occurs after 1-2 months of consistent therapy 2

Guideline Recommendations for Primary Monosymptomatic Nocturnal Enuresis in Children

1. Initial Assessment and Evaluation

  • Perform a urinalysis before any therapy to rule out diabetes mellitus, urinary‑tract infection, or renal disease. 4
  • Complete a frequency‑volume chart for at least one week (ideally recording intake and output for 2 days) to differentiate nocturnal polyuria from reduced bladder capacity. 5, 6

2. First‑Line Therapeutic Options (International Children’s Continence Society)

  • Offer either an enuresis alarm or desmopressin as first‑line treatment after the brief evaluation; reassurance alone is insufficient for a child aged ≈ 6 years with primary monosymptomatic nocturnal enuresis and a positive family history. 5, 6
  • Enuresis alarm – preferred for families who are motivated and for children who do not have nocturnal polyuria but exhibit low voided volumes. 5, 6
  • Success of the alarm program depends on written instructions, a treatment contract, frequent monitoring visits, overlearning of the response, and intermittent reinforcement before discontinuation. 4
  • Desmopressin – preferred for children who demonstrate nocturnal polyuria with otherwise normal bladder reservoir function. 5, 6

3. Selecting the Appropriate First‑Line Modality

  • Use the frequency‑volume chart to guide therapy choice:
    • If nocturnal polyuria with normal voided volume is identified → prescribe desmopressin. 5
    • If low voided volume without polyuria is identified → prescribe an enuresis alarm. 5

4. Common Misconceptions

  • Primary nocturnal enuresis is not a toilet‑training problem; by age 6 years daytime toilet training should already be established, and nocturnal bladder control requires specific interventions. 7

5. Management When First‑Line Therapy Fails

  • Switch to the alternative first‑line option (e.g., from alarm to desmopressin or vice‑versa). 5, 6
  • Consider combination therapy (alarm + desmopressin) for cases resistant to single‑modality treatment. 5
  • Re‑evaluate for missed comorbidities such as constipation, sleep‑disordered breathing, or overactive bladder. 5
  • Anticholinergic agents may be introduced as second‑line therapy only if detrusor overactivity is suspected. 5

6. Essential Clinical Practices

  • Never omit the frequency‑volume chart; it is critical for individualizing therapy and predicting treatment response. 5